Targeting transposon mutagenesis to a specific tissue facilitates screening for tumor-associated genes and tracking of tumor lineages.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Keng, V.W. et al. Nat Biotechnol. 27, 264–274 (2009).
Dupuy, A.J. et al. Nature 436, 221–226 (2005).
Collier, L.S. et al. Nature 436, 272–276 (2005).
Uren, A.G., Kool, J., Berns, A. & van Lohuizen, M. Oncogene 21, 7656-7672 (2005).
Boccaccio, C. et al. Nature 434, 396–400 (2005).
Takeo, S. et al. Cancer Genet. Cytogenet. 130, 127–132 (2001).
Katyal, S. et al. Radiology 216, 698–703 (2000).
Kustikova, O.S. et al. Blood 109, 1897–1907 (2007).
Garcia, S.B., Park, H.S., Novelli, M. & Wright, N.A. J. Pathol. 187, 61–81 (1999).
Parmigiani, G. et al. Genomics 93, 17–21 (2009).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Uren, A., Berns, A. Jump-starting cancer gene discovery. Nat Biotechnol 27, 251–252 (2009). https://doi.org/10.1038/nbt0309-251
Issue Date:
DOI: https://doi.org/10.1038/nbt0309-251